We look back to a long history in biopharmaceuticals development and manufacturing. We’ve been one of the first companies in Europe which invested in large-scale facilities for manufacturing of biopharmaceutical medicines. With the growing need for such therapies in the late 1990‘s we started to...
We look back to a long history in biopharmaceuticals development and manufacturing. We’ve been one of the first companies in Europe which invested in large-scale facilities for manufacturing of biopharmaceutical medicines. With the growing need for such therapies in the late 1990‘s we started to...
The biopharmaceutical industry in Uzbekistan Commercial and technological opportunities for UK companiesRimmington, ACarr, BAsbridge, S.M
Sanj K. Patel, CEO and Chairman of the Board of Kiniksa Pharmaceuticals, brings more than 25 years of experience in the biopharmaceutical industry to build a company that puts patients first. Watch Video Patient Stories Serving those who
191 projects in our pipeline View pipeline Learn about our cell therapy ambition The Discovery Centre in Cambridge (UK) is one of our global science centres Explore all our science centres Sustainability at AstraZeneca Corporate Press Release ...
Join Pfizer in the Fight Against Cancer Nearly 41% of Americans will receive a cancer diagnosis during their lifetime. By understanding their risks, people can take action to help detect it early, when it's most treatable. We’re working with our partners at the American Cancer Society to ...
Both genomics and proteomics are contributing to understanding and determining more targets which involved in the development of human disease, and will en... 陈惠鹏 - 《中国生物工程杂志》 被引量: 4发表: 2005年 加载更多研究点推荐 Biopharmaceutical Companies Record 235 Medicines Diabetes 引用走势 20...
First, a dynamic data envelopment analysis model is adopted to evaluate the performance of the U.S. biopharmaceutical companies. Then, ordinary least squares regression is used to explore the effects of three patent‐related variables (patent counts, citations, and claims) and R&D spikes on ...
Global News: The fast growth of the global biopharmaceutical market has prompted global bio/pharma companies to increase their R&D investment in biologics 来自 ResearchGate 喜欢 0 阅读量: 13 作者: JJ Zhang 摘要: We began by suggesting that our central concern was to discuss the contribution made...
The biopharmaceutical industry has witnessed a significant shift toward outsourcing, driven by companies' increased focus on core competencies and the need for specialized expertise. According to BioPlan Associates' 19th Annual Report published in April 2022, 86.9% of biopharmaceutical respondents reported ...